卡斯尔生物科技 CSTL
$32.52 −$1.68 (-4.91%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $32.52 0.00%
开盘$34.56
昨收$34.20
当日区间$31.81 – $35.69
成交量981.8K
市值$1.00B
市盈率（TTM）–
股息率–
财报
财报日平均波动±12.7%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+32.8%
最差反应-26.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 30 Jul 2026 | After Market | ±17.7% | +4.52% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±22.6% | -22.26% | 符合区间 |
| 2025/Q4 | 26 Feb 2026 | After Market | ±13.9% | -7.25% | 符合区间 |
| 2025/Q3 | 3 Nov 2025 | After Market | ±14.0% | +21.70% | 超出定价预期 |
| 2025/Q2 | 4 Aug 2025 | After Market | ±13.1% | +32.83% | 超出定价预期 |
| 2025/Q1 | 5 May 2025 | After Market | ±14.0% | -11.36% | 符合区间 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±16.4% | -14.24% | 符合区间 |
| 2024/Q3 | 4 Nov 2024 | After Market | ±18.1% | -7.40% | 符合区间 |
| 2024/Q2 | 5 Aug 2024 | After Market | ±20.6% | +13.96% | 符合区间 |
| 2024/Q1 | 2 May 2024 | After Market | ±11.6% | +6.52% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±15.7% | -25.95% | 超出定价预期 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±15.6% | +7.99% | 符合区间 |
| 2023/Q2 | 2 Aug 2023 | After Market | ±16.5% | +11.79% | 符合区间 |
| 2023/Q1 | 3 May 2023 | After Market | – | -3.93% | – |
| 2022/Q4 | 28 Feb 2023 | After Market | ±9.5% | -9.21% | 符合区间 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±17.5% | -2.02% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$103.55M+20.1% YoY
营业利润-$3.07M+27.8% YoY
净利润-$2.06M-145.5% YoY
摊薄每股收益-$0.07-146.7% YoY
自由现金流$6.55M-43.3% YoY
经营现金流$15.20M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率77.3%
营业利润率-9.0%
净利率-5.4%
净资产收益率-4.2%
资产收益率-3.5%
投入资本回报率-5.1%
流动比率6.04
负债/资产比率16.2%
现金及投资$266.81M
总负债$35.23M
净现金（净负债）$231.57M
暂无评论——快来第一个聊聊 CSTL。
登录后参与讨论。